nandrolone has been researched along with pentoxifylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ahmed, MA; El-Awdan, SA | 1 |
2 other study(ies) available for nandrolone and pentoxifylline
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression.
Topics: Acetylcholine; Animals; Antioxidants; Brain; Down-Regulation; Heme Oxygenase-1; Male; Mental Disorders; Nandrolone; Nandrolone Decanoate; Neuroprotective Agents; Neurotransmitter Agents; NF-E2-Related Factor 2; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Thioctic Acid; Up-Regulation | 2015 |